BofA Finance LLC has announced the launch of a new offering of Auto-Callable Enhanced Return Notes valued at $833,000. This financial product is linked to the Nasdaq-100 Futures Excess Return Index and is fully guaranteed by Bank of America Corporation. This strategic move is significant as it showcases BofA Finance's commitment to expanding its product offerings in a competitive landscape.
The filing, dated October 29, 2026, indicates that the notes will issue on October 30, 2026, with an approximate term of five years unless called prior to maturity. The notes are designed to provide investors with potential upside exposure to the Nasdaq-100 index, reflecting BofA Finance's innovative approach to meet investor demand.
Background
BofA Finance LLC, classified under the SIC code 6021 as a National Commercial Bank, is a subsidiary of Bank of America Corporation. The company is incorporated in Delaware and operates from its headquarters in Charlotte, North Carolina. BofA Finance focuses on providing various financial products and services to its clients, leveraging the extensive resources of its parent company.
What the Filing Says
The SEC filing states, "The Auto-Callable Enhanced Return Notes Linked to the Nasdaq-100 Futures Excess Return Index, due October 30, 2031, priced on October 27, 2026, and will issue on October 30, 2026." The notes will not be listed on any securities exchange, and payments will depend on the performance of the underlying index.
Impact
This offering may impact both investors and competitors in the national commercial banking sector. Investors seeking innovative financial products may find these notes appealing due to their potential for enhanced returns linked to a major index. Competitors may need to consider similar offerings to remain competitive in this evolving market.
What's Next
The filing does not say what happens next.
Read Next
Workers United Files to Sell $8.4 Million in Amalgamated Stock
Carvana Co. files to sell 10 million shares of stock
Platford Giles Richard to Sell 55,617 Takeda Shares
Takeda's Teresa Bitetti to Sell 46,609 Shares Amid Tax Obligations
Kiniksa Pharmaceuticals reports significant stock sale by officer
Moat Ross to Sell Over 103,000 Shares of Kiniksa Pharmaceuticals










